431 related articles for article (PubMed ID: 30230950)
1. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
[TBL] [Abstract][Full Text] [Related]
2. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
3. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey).
Koga K; Fukui M; Fujisawa M; Suzukamo Y
J Obstet Gynaecol Res; 2023 Oct; 49(10):2528-2537. PubMed ID: 37524334
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study.
Chen J; Li Y; Wang Z; McCulloch P; Hu L; Chen W; Liu G; Li J; Lang J;
BJOG; 2018 Feb; 125(3):354-364. PubMed ID: 28421665
[TBL] [Abstract][Full Text] [Related]
6. Alternatives to hysterectomy: The burden of fibroids and the quality of life.
Fortin C; Flyckt R; Falcone T
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():31-42. PubMed ID: 29157931
[TBL] [Abstract][Full Text] [Related]
7. Burden of symptomatic uterine fibroids in Canadian women: a cohort study.
Laberge PY; Vilos GA; Vilos AG; Janiszewski PM
Curr Med Res Opin; 2016; 32(1):165-75. PubMed ID: 26455364
[TBL] [Abstract][Full Text] [Related]
8. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
Coyne KS; Margolis MK; Murphy J; Spies J
Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Fertility Goals on Long-term Quality of Life in Reproductive-aged Women Who Underwent Myomectomy versus Hysterectomy for Uterine Fibroids.
Frisch EH; Mitchell J; Yao M; Llarena N; Omosigho UR; DeAngelo L; Arakelian M; Bradley L; Falcone T
J Minim Invasive Gynecol; 2023 Aug; 30(8):642-651. PubMed ID: 37044261
[TBL] [Abstract][Full Text] [Related]
10. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL).
Harding G; Coyne KS; Thompson CL; Spies JB
Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of the psychosocial impact of fibroids before and after treatment.
Go VAA; Thomas MC; Singh B; Prenatt S; Sims H; Blanck JF; Segars JH
Am J Obstet Gynecol; 2020 Nov; 223(5):674-708.e8. PubMed ID: 32474012
[TBL] [Abstract][Full Text] [Related]
12. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial.
de Bruijn AM; Ankum WM; Reekers JA; Birnie E; van der Kooij SM; Volkers NA; Hehenkamp WJ
Am J Obstet Gynecol; 2016 Dec; 215(6):745.e1-745.e12. PubMed ID: 27393268
[TBL] [Abstract][Full Text] [Related]
13. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
[TBL] [Abstract][Full Text] [Related]
14. Uterine fibroids: a review of health-related quality of life assessment.
Williams VS; Jones G; Mauskopf J; Spalding J; DuChane J
J Womens Health (Larchmt); 2006 Sep; 15(7):818-29. PubMed ID: 16999637
[TBL] [Abstract][Full Text] [Related]
15. Impact of uterine fibroids on quality of life: a national cross-sectional survey.
Hervé F; Katty A; Isabelle Q; Céline S
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225
[TBL] [Abstract][Full Text] [Related]
16. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
Stewart EA; Al-Hendy A; Lukes AS; Madueke-Laveaux OS; Zhu E; Proehl S; Schulmann T; Marsh EE
Am J Obstet Gynecol; 2024 Feb; 230(2):237.e1-237.e11. PubMed ID: 37863160
[TBL] [Abstract][Full Text] [Related]
17. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire.
Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K
Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082
[TBL] [Abstract][Full Text] [Related]
18. Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids.
Orellana M; Riggan KA; DSouza K; Stewart EA; Venable S; Balls-Berry JE; Allyse MA
J Racial Ethn Health Disparities; 2022 Aug; 9(4):1184-1191. PubMed ID: 34013445
[TBL] [Abstract][Full Text] [Related]
19. Uterine Fibroid Symptom and Health-related Quality of Life Questionnaire: a Chinese translation and validation study.
Yeung SY; Kwok JWK; Law SM; Chung JPW; Chan SSC
Hong Kong Med J; 2019 Dec; 25(6):453-459. PubMed ID: 31796639
[TBL] [Abstract][Full Text] [Related]
20. Influence of Ethnicity on Clinical Presentation and Quality of Life in Women With Uterine Fibroids: Results From a Prospective Observational Registry.
Murji A; Bedaiwy M; Singh SS; Bougie O;
J Obstet Gynaecol Can; 2020 Jun; 42(6):726-733.e1. PubMed ID: 31882290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
